Financhill
Back

Virtus Investment Partners Vs. Novo Nordisk AS Industry Stock Comparison

Buy
54

VRTS
Virtus Investment Partners

Last Price:
$220.31
Seasonality Move:
2.04%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Buy
54
Virtus Investment Partners (VRTS) is a Buy

Is Virtus Investment Partners a Buy, Sell or Hold?

  • The current Virtus Investment Partners [VRTS] share price is $221.00. The Score for VRTS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • VRTS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

VRTS Stock Price Chart

What is Virtus Investment Partners's stock price today?

  • The Virtus Investment Partners share price today is $221.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTS is experiencing slight buying pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRTS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.38 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: 62741 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (231.02 - 248.8) Sell
Bollinger Bands (100): (201.5 - 235.1) Buy

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

VRTS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 232.25 Sell
20-day SMA: 240.88 Sell
50-day SMA: 231.5 Sell
200-day SMA: 224.64 Sell
8-day EMA: 229.68 Sell
20-day EMA: 235.48 Sell
50-day EMA: 231.65 Sell
200-day EMA: 222.87 Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

Virtus Investment Partners Earnings Growth & VRTS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.66 per share, and an increase next year of $3.49 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Virtus Investment Partners Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):